Hyperosmolar nonketotic syndrome with hypernatremia: how can we monitor treatment?

Abstract:

:We report the case of a 62 year-old symptomatic patient with severe hyperglycemic hyperosmolality associated with hypernatremia. During treatment, the progressive decrease in serum tonicity, which resulted in the amelioration of the neurological symptoms, followed the decrease in serum glucose and mainly the corrected serum sodium levels rather than the decrease in the uncorrected serum sodium levels. The case illustrates the usefulness of glucose - corrected serum sodium levels to monitor treatment in such conditions in order to avoid neurological consequences caused by the decrease in serum osmolality.

journal_name

Diabetes Metab

journal_title

Diabetes & metabolism

authors

Liamis G,Gianoutsos C,Elisaf MS

subject

Has Abstract

pub_date

2000-11-01 00:00:00

pages

403-5

issue

5

eissn

1262-3636

issn

1878-1780

pii

MDOI-DM-11-2000-26-5-1262-3636-101019-ART8

journal_volume

26

pub_type

杂志文章
  • Managing the manager: gut microbes, stem cells and metabolism.

    abstract::One major discovery of the last decade in the field of metabolic diseases is that the microorganisms comprising the gut microbiota are now considered a metabolic "organ", modulating multiple functions of the host, such as intestinal immune system maturation, adiposity, cardiac metabolism, liver triglyceride storage, a...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/j.diabet.2013.12.004

    authors: Serino M,Blasco-Baque V,Nicolas S,Burcelin R

    更新日期:2014-06-01 00:00:00

  • A new challenge for diabetologists and geriatricians!

    abstract::The "Société Française de Gériatrie et Gérontologie" (SFGG) and "Association de Langue Française pour l'Etude du Diabète et des Maladies Métaboliques" (ALFEDIAM) have decided to join their efforts in actions to improve the management and treatment of the elderly diabetic patients. New knowledge brought by the fundamen...

    journal_title:Diabetes & metabolism

    pub_type: 社论

    doi:10.1016/s1262-3636(05)73646-6

    authors: Tréton J

    更新日期:2005-12-01 00:00:00

  • Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.

    abstract:OBJECTIVE:We assessed the efficacy of a modest weight loss (1.5 +/- 0.3 kg) and simultaneous rapid improvement in glycemic control on fasting an post-prandial lipoprotein sub-fractions in nine overweight (BMI=28 +/- 1.7 kg/m(2)) well controlled Type 2 diabetic patients (HbA(1c)=7.3 +/- 0.1%). MATERIAL AND METHODS:They...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Ybarra J,James RW,Makoundou V,Bioletto S,Golay A

    更新日期:2001-12-01 00:00:00

  • Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study.

    abstract:AIMS:Reactive dicarbonyl compounds, such as methylglyoxal (MGO), rise during an oral glucose tolerance test (OGTT), particularly in (pre)diabetes. Fasting MGO levels are associated with chronic kidney disease (CKD) and cardiovascular disease (CVD) in patients with poorly controlled type 2 diabetes mellitus (T2DM). Yet,...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2020.02.002

    authors: Hanssen NMJ,Scheijen JLJM,Houben AJHM,van de Waarenburg M,Berendschot TTJM,Webers CAB,Reesink KD,van Greevenbroek MMJ,van der Kallen C,Schaper NC,Schram MT,Henry RMA,Stehouwer CDA,Schalkwijk CG

    更新日期:2020-02-10 00:00:00

  • Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications.

    abstract::A major aim of glucose-lowering therapy in people with diabetes is to delay or prevent the late-developing complications of diabetes that threaten the quality and duration of life. While intensive interventions to control hyperglycaemia may impair well-being to some extent, the balance of quality of life is usually hi...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/s1262-3636(07)70148-9

    authors: Consoli A,Gomis R,Halimi S,Home PD,Mehnert H,Strojek K,Van Gaal LF

    更新日期:2004-12-01 00:00:00

  • Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients.

    abstract::TNF-alpha is considered as one of the potential determinants of insulin resistance. However several data suggest that TNF-alpha expression itself, could be modulated by the degree of adiposity and/or plasma insulin levels. To clarify the determinants of plasma TNF-alpha levels in type 2 diabetes mellitus, we studied t...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Bertin E,Nguyen P,Guenounou M,Durlach V,Potron G,Leutenegger M

    更新日期:2000-05-01 00:00:00

  • Epidemiological data on postprandial glycaemia.

    abstract::There are few studies on the effects of postprandial hyperglycaemia, and usually it is assumed that its effects are the same as those of post-glucose-load hyperglycaemia, following a standard 75 g oral glucose tolerance test. There is some evidence from a study with blood drawn following ingestion of a standardised "d...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(06)70478-5

    authors: Balkau B,Eschwège E

    更新日期:2006-09-01 00:00:00

  • Regulation of in vivo ketogenesis: role of free fatty acids and control by epinephrine, thyroid hormones, insulin and glucagon.

    abstract::The production of ketone bodies (KB) is dependent on the amount of free fatty acids (FFA) supplied to the liver and on the hepatic metabolic fate of fatty acids and their orientation towards oxidation and ketogenesis or reesterification. In vivo ketogenesis can thus be regulated at the pre-hepatic (lipolysis) or hepat...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Beylot M

    更新日期:1996-10-01 00:00:00

  • Anthropometric markers for detection of the metabolic syndrome in adolescents.

    abstract:OBJECTIVES:This study aimed to estimate, in a large group of Algerian adolescents, the prevalence of the metabolic syndrome (MetS), using four definitions (by Cook, De Ferranti, Viner and the IDF), and to test the validity of unique thresholds of waist circumference, waist/height ratio and BMI in screening for the MetS...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2014.07.001

    authors: Benmohammed K,Valensi P,Benlatreche M,Nguyen MT,Benmohammed F,Pariès J,Khensal S,Benlatreche C,Lezzar A

    更新日期:2015-04-01 00:00:00

  • Methods for the screening and diagnosis of gestational diabetes mellitus between 24 and 28 weeks of pregnancy.

    abstract::The aim of this review is to provide answers to the question “How does one screen for and diagnose gestational diabetes mellitus (GDM) between 24 and 28 weeks gestation?” Two methods are currently widely used: a one-step approach (the 75g-Oral Glucose Tolerance Test, OGTT) and a two-step approach (the 50g Glucose Chal...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/j.diabet.2010.11.008

    authors: Virally M,Laloi-Michelin M

    更新日期:2010-12-01 00:00:00

  • Relationship between achieved personalized glycaemic targets and monitoring of clinical events in elderly diabetic patients.

    abstract:AIM:Recent guidelines for the management of type 2 diabetes (T2DM) in the elderly recommend adjusting the therapeutic target (HbA1c) according to the patient's health. Our study aimed to explore the association between achieving the recommended personalized HbA1c target and the occurrence of major clinical events under...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.diabet.2016.05.008

    authors: Bucher S,Panjo H,Al-Salameh A,Bauduceau B,Benattar-Zibi L,Bertin P,Berrut G,Corruble E,Danchin N,Derumeaux G,Doucet J,Falissard B,Forette F,Hanon O,Ourabah R,Pasquier F,Piedvache C,Pinget M,Becquemont L,Ringa V,re

    更新日期:2017-02-01 00:00:00

  • Metabolic effects of SGLT-2 inhibitors beyond increased glucosuria: A review of the clinical evidence.

    abstract::Sodium-glucose cotransporter type 2 (SGLT-2) inhibitors (canagliflozin, dapagliflozin, empagliflozin) are new glucose-lowering agents that exert their therapeutic activity independently of insulin by facilitating glucose excretion through the kidneys. However, this simple renal mechanism that results in sustained gluc...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/S1262-3636(14)72689-8

    authors: Scheen AJ,Paquot N

    更新日期:2014-12-01 00:00:00

  • Growth factors and diabetic retinopathy.

    abstract::Preretinal neovascularization and chronic retinal oedema are the two major sight-threatening complications that can occur during diabetic retinopathy. Ocular neovascularization is strongly associated with retinal ischaemia, and growth factors have been implicated in its pathogenesis. The ischaemic retina is assumed to...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Paques M,Massin P,Gaudric A

    更新日期:1997-04-01 00:00:00

  • New-onset diabetes after transplantation: risk factors and clinical impact.

    abstract::With improvements in patient and graft survival, increasing attention has been placed on complications that contribute to long-term patient morbidity and mortality. New-onset diabetes after transplantation (NODAT) is a common complication of solid-organ transplantation, and is a strong predictor of graft failure and c...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/j.diabet.2010.09.003

    authors: Räkel A,Karelis AD

    更新日期:2011-02-01 00:00:00

  • [Role of bariatric surgery in the obese diabetic].

    abstract::Bariatric surgery can be proposed to address severe obesity associated with comorbid conditions, when medical treatment has failed. Three surgical techniques are currently available, including 2 using coelioscopy. Short term results are encouraging regarding weight loss, which is linked with a reduction in comorbid co...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Simon C

    更新日期:2000-06-01 00:00:00

  • Diabetes-related metabolic perturbations in cardiac myocyte.

    abstract::Although the pathogenesis of diabetic cardiomyopathy is poorly understood, recent evidence implicates perturbations in cardiac energy metabolism. Whereas mitochondrial fatty acid oxidation is the chief energy source for the normal postnatal mammalian heart, the relative contribution of glucose utilization pathways is ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/S1262-3636(08)70096-X

    authors: Feuvray D,Darmellah A

    更新日期:2008-02-01 00:00:00

  • Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review.

    abstract:BACKGROUND:Insulin aspart (IAsp) is one of the three rapid-acting insulin analogues (RAAs) registered for the treatment of diabetes. However, there is an ongoing debate concerning the efficacy and safety of RAAs. For this reason, a systematic review-based study was performed to compare clinical outcomes of treatment wi...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.diabet.2010.12.003

    authors: Rys P,Pankiewicz O,Łach K,Kwaskowski A,Skrzekowska-Baran I,Malecki MT

    更新日期:2011-06-01 00:00:00

  • Adipose tissue is influenced by hypoxia of obstructive sleep apnea syndrome independent of obesity.

    abstract:AIMS:Obstructive sleep apnea syndrome (OSAS) is associated with increased cardiovascular risk and diabetes independent of obesity. We investigated whether adipose tissue dysfunction is exacerbated due to increased tissue hypoxia. METHODS:Adipose tissue (AT) oxygenation was measured with a Clarke-type electrode (pATO2)...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2016.12.002

    authors: Thorn CE,Knight B,Pastel E,McCulloch LJ,Patel B,Shore AC,Kos K

    更新日期:2017-06-01 00:00:00

  • Parathyroid hormone is associated with incident diabetes in white, but not black adults: The Atherosclerosis Risk in Communities (ARIC) Study.

    abstract:OBJECTIVE:Accumulating evidence has linked elevated parathyroid hormone (PTH) with insulin resistance, beta cell dysfunction and dysglycaemia, however, its role in the development of diabetes is largely unclear, particularly among non-whites. We sought to examine the association of PTH with the incidence of diabetes. ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2015.12.004

    authors: Reis JP,Selvin E,Pankow JS,Michos ED,Rebholz CM,Lutsey PL

    更新日期:2016-06-01 00:00:00

  • Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects.

    abstract:OBJECTIVE:To determine the relationship between CRP levels and the components of MS in normal glucose tolerant (NGT), impaired glucose tolerant (IGT), and Type 2 diabetic subjects. MATERIAL AND METHODS:A based cross-sectional population study was performed. Eligible subjects, men and non-pregnant women, 30 to 64 year ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70009-5

    authors: Guerrero-Romero F,Rodríguez-Morán M

    更新日期:2003-02-01 00:00:00

  • Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease.

    abstract::Protease inhibitor treatment has dramatically improved rates of morbidity and mortality in HIV-infected patients. However, it has recently been shown that this medication is associated with long-term side effects characterized by metabolic, clinical and biological alterations. These modifications have been described i...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Vigouroux C,Gharakhanian S,Salhi Y,Nguyên TH,Adda N,Rozenbaum W,Capeau J

    更新日期:1999-11-01 00:00:00

  • Chronic lipoic acid treatment worsens energy imbalances in streptozotocin-induced diabetic rats.

    abstract:AIM:Our objective was to verify the energy balance in streptozotocin-induced diabetic rats chronically treated with lipoic acid (LA). METHODS:Diabetes was induced in rats by streptozotocin and the animals divided into four groups, comprising controls and diabetic rats, with each group receiving either daily intraperit...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2008.08.005

    authors: Luz J,Zemdegs JC,Amaral LS

    更新日期:2009-04-01 00:00:00

  • Skeletal muscle magnesium content in identical twins, discordant for type 2 diabetes.

    abstract:BACKGROUND:Low magnesium (Mg) status has been implied as a factor in the development of type 2 diabetes mellitus (DM) and its complications. We therefore studied Mg-status in identical twins, discordant for type 2 DM and in matched controls. Through correlation analysis, possible associations between Mg-status and gluc...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Djurhuus MS,Vaag A,Altura BM,Altura BT,Klitgaard NA

    更新日期:2002-06-01 00:00:00

  • Beneficial effects of metformin on haemostasis and vascular function in man.

    abstract::Type 2 diabetes is characterised by insulin resistance in association with clustering of atherothrombotic risk factors (dysglycaemia, hyperinsulinaemia, hypertension, raised triglyceride, low HDL cholesterol and increased levels of plasminogen activator inhibitor-1 (PAI-1) and clotting factor VII). There is a 3-5 fold...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/s1262-3636(03)72787-6

    authors: Grant PJ

    更新日期:2003-09-01 00:00:00

  • HBA1c: clinical and biological agreement for standardization of assay methods. Report by the experts of ALFEDIAM (Association de Langue Française pour lEtude du Diabète et des Maladies Métabolique) and SFBC (Société Française de Biologie Clinique).

    abstract::Glycohaemoglobin, and particularly haemoglobin A1c(HbA1c), assays have been used for many years to retrospectively evaluate the glycaemic control of diabetic patients. Cut-off values have been established for deciding treatment modifications. The techniques used in the laboratories however exhibit varying quality, and...

    journal_title:Diabetes & metabolism

    pub_type: 指南,杂志文章

    doi:

    authors: Gillery P,Bordas-Fonfrède M,Chapelle JP,Drouin P,Hue G,Lévy-Marchal C,Périer C,Sélam JL,Slama G,Thivolet C,Vialettes B

    更新日期:1999-09-01 00:00:00

  • Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month ex

    abstract:AIMS:To compare insulin glargine 300 U/mL (Gla-300) with glargine 100 U/mL (Gla-100) in Japanese adults with uncontrolled type 2 diabetes on basal insulin and oral anti-hyperglycaemic drugs over 12 months. METHODS:EDITION JP 2 was a randomised, open-label, phase 3 study. Following a 6-month treatment period, participa...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.diabet.2017.03.001

    authors: Terauchi Y,Koyama M,Cheng X,Sumi M,Riddle MC,Bolli GB,Hirose T,EDITION JP 2 study group.

    更新日期:2017-10-01 00:00:00

  • The Ala45Thr polymorphism of NEUROD1 is associated with type 1 diabetes in Brazilian women.

    abstract:BACKGROUND:NEUROD1 encodes a transcription factor expressed in the endocrine pancreas, and involved in beta-cell development, function and mechanisms of apoptosis. In this study, we investigated the association of a frequent polymorphism in exon 2 of NEUROD1 (G > A; Ala45Thr) with Type 1 diabetes in Brazilian subjects....

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70237-9

    authors: Oliveira CS,Hauache OM,Vieira JG,Maciel RM,Sjöroos M,Canani LH,Velho G,Gross JL,Reis AF

    更新日期:2005-12-01 00:00:00

  • Metabolic syndrome and Framingham risk score for prediction of cardiovascular events in Caribbean Indian patients with blood glucose abnormalities.

    abstract:OBJECTIVE:To evaluate the metabolic syndrome (MS) and Framingham risk score (FRS) as predictors of cardiovascular (CV) events in Caribbean Indian patients who have type 2 diabetes (T2D) or impaired glucose tolerance (IGT). METHOD:A longitudinal and retrospective study was conducted involving patients classified as T2D...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2007.10.005

    authors: Jaquet A,Deloumeaux J,Dumoulin M,Bangou J,Donnet JP,Foucan L

    更新日期:2008-04-01 00:00:00

  • Role of metalloproteases and inhibitors in the occurrence and progression of diabetic renal lesions.

    abstract::Renal remodelling in hyperinsulinic/insulinopenic states is mediated by glucotoxicity, endothelial dysfunction and vascular and nephron collagen turnover. Hypertensive and renal links are renewed by renoprotective interventions of renin-angiotensin. Vasoactive peptide processing and vascular collagen deposition are un...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Zaoui P,Cantin JF,Alimardani-Bessette M,Monier F,Halimi S,Morel F,Cordonnier D

    更新日期:2000-07-01 00:00:00

  • Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetes.

    abstract::Incretin therapies such as dipeptidyl peptidase-4 inhibitors (DPP-4Is) and GLP-1 receptor agonists (GLP-1RAs) have become well-established treatments for type 2 diabetes. Both drug classes reduce blood glucose through physiological pathways mediated by the GLP-1 receptor, resulting in glucose-dependent enhancement of ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/j.diabet.2012.08.002

    authors: Vora J,Bain SC,Damci T,Dzida G,Hollander P,Meneghini LF,Ross SA

    更新日期:2013-02-01 00:00:00